Chi Sheng Pharma & Biotech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Chi Sheng Pharma & Biotech Co Ltd

Watchlist Manager

Watchlist

Price: 28.85 TWD 0.35% Market Closed

Market Cap: NT$1.7B

C	Chi Sheng Pharma & Biotech Co Ltd TPEX:4111	TW
	Gr Sarantis SA OTC:SRTSF	GR
	Bloomberry Resorts Corp OTC:BLBRF	PH
	Petroleo Brasileiro SA Petrobras NYSE:PBR	BR
	DiaSorin SpA F:34D	IT
	Kioson Komersial Indonesia Tbk PT IDX:KIOS	ID
C	Commerzbank AG XMUN:CBK	DE
S	STAK Inc NASDAQ:STAK	CN
	Gaya Abadi Sempurna Tbk PT IDX:SLIS	ID
V	Voksel Electric Tbk PT IDX:VOKS	ID
I	International Business Machines Corp XHAM:IBM	US

Profitability Summary

Chi Sheng Pharma & Biotech Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

39%

Sustainable 3Y Average Gross Margin

36%

Gross Margin is Increasing

34% > 39%

Healthy Operating Margin

14%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

8% > 14%

Healthy Net Margin

13%

Low 3Y Average Net Margin

10%

Net Margin is Increasing

11% > 13%

Exceptional Free Cash Flow Margin

15%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.